Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VaxartMEX:VXRT 50 EV-to-OCF is 5.13 as of Aug. 03, 2026. GuruFocus rates MEX:VXRT with a GF Score™ of 50/100. The stock has 3 warning signs investors should review. Among 1,410 Biotechnology companies, Vaxart ranks worse than 80.85% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Vaxart's Enterprise Value is MXN1,347 Mil.
Vaxart's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was MXN262 Mil. Therefore, Vaxart's EV-to-OCF for today is 5.13.
The historical rank and industry rank for Vaxart's EV-to-OCF or its related term are showing as below:
MEX:VXRT'
s EV-to-OCF Range Over the Past 10 Years
Min: -95.68 Med: -0.91 Max: 17.23
Current: 5.09
During the past 13 years, the highest EV-to-OCF of Vaxart was 17.23. The lowest was -95.68. And the median was -0.91.
MEX:VXRT's EV-to-OCF is ranked worse than 80.85% of 1410
companies
in the Biotechnology industry
Industry Median: -3.23
vs MEX:VXRT: 5.09
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-03), Vaxart's stock price is MXN12.00.
Vaxart's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN2.622. Therefore, Vaxart's PE Ratio (TTM) for today is 4.58.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vaxart's share price for today is MXN12.00.
Vaxart's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN2.622.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Vaxart EV-to-OCF Related Terms
Vaxart EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Vaxart's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:VXRT vs VTVT, SPRB, ENGN: EV-to-OCF Comparison
For the Biotechnology subindustry, Vaxart's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxart EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vaxart's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Vaxart's EV-to-OCF falls into.
Vaxart's current Enterprise Value is MXN1,347 Mil.
Vaxart's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN262 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxart (MEX:VXRT) has a EV-to-OCF of 5.13 as of Aug. 03, 2026. According to the industry distribution chart, Vaxart ranks #1140 out of 1410 companies in the Biotechnology industry, placing it in the top 80.9%.
Is Vaxart's EV-to-OCF too high?
Vaxart's current EV-to-OCF is 5.13. Based on the distribution chart, Vaxart ranks #1140 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vaxart has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's EV-to-OCF compare to VTVT and SPRB?
According to the Biotechnology industry distribution chart, Vaxart ranks #1140 out of 1410 companies for EV-to-OCF. This places Vaxart in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Vaxart's current EV-to-OCF is 5.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (MEX:VXRT) has a current EV-to-OCF of 5.13. The current EV-to-OCF is 5.13. Vaxart's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Vaxart (MEX:VXRT), the current EV-to-OCF is 5.13 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
50GF Score
Get the complete analysis for MEX:VXRT
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:VXRT has been successfully added to your 
